Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gala Health vs Pallas Health

By GLP-1 ScorecardUpdated

Gala HealthFactor scores not reassessed.
Site position #11

Higher score

Pallas HealthFactor scores not reassessed.
Site position #142

Lower score

Score comparison

Gala Health has the higher recorded score — 82.9/100 to 69.3/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Before you choose

Before comparing the headline prices, the Gala Health review and the Pallas Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Gala Health vs Peptivo and Get Thin MD vs Pallas Health compare each of them with another graded program, and the list of alternatives to Gala Health ranks the programs closest to Gala Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueGala Health +29
84
55
Dose & formulationGala Health +7
83
76
Clinical oversightGala Health +1
85
84
Labs & monitoringGala Health +31
83
52
FulfillmentGala Health +2
88
86
Contract termsPallas Health +2
66
68
Gala Health · top barPallas Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricGala HealthPallas Health
WeighScore82.9/10069.3/100
GradeB−C
Site position#11#142
SemaglutideFrom $69/mo on the annual plan, billed once a year (campaign shows $129/mo; offers conflict—confirm billing term)$139 first period, then $199 every four weeks (compounded; confirm selected quote)
TirzepatideFrom $99/mo on the annual plan, billed once a year (campaign shows $179/mo; offers conflict—confirm term)$179 first period, then $299 every four weeks (compounded; confirm selected quote)
CoverageCoverage wording differs: all 50 on homepage, most U.S. states in campaignConfirm treatment and visit requirements for your state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Gala Health

Site position #11 · B−

Factor scores not reassessed.

Strengths

  • Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
  • Brand-name Ozempic path and broader menopause/HRT services listed
  • Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking

What to consider

  • Annual-plan and no-contract campaign presentations differ; the lowest prices are advertised as billed once a year
  • Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
  • Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
  • Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer
Pallas Health

Site position #142 · C

Factor scores not reassessed.

Strengths

  • Publishes first-period and four-week renewal amounts
  • Explains when the charge is triggered and how to cancel future renewal
  • Terms link to a pharmacy partner directory

What to consider

  • Annual monthly equivalents do not establish the selected debit
  • Once prescribed, the current cycle ordinarily is not prorated or refunded
  • The six-month promise has separate eligibility and timing requirements

Featured provider

Gala Health

Factor scores not reassessed.

Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard